Labs Lose a Battle But May Win the War Over Market-Based Pricing
In its crusade to get CMS to fix its warped Protecting Access to Medicare Act of 2014 (PAMA) market-based Medicare Part B pricing scheme, the lab industry lost a battle but may still end up winning the war. Here’s a rundown of the rollercoaster PAMA developments and...CMS Delays New Rule Providing Automatic Medicare Coverage of Breakthrough Devices
...
MedPAC Explores Simplified PAMA Reporting to Cut Burdens & Restore Lab Prices
...
Manufacturers Wait Anxiously for CMS Decision on Automatic Medicare Coverage of MCIT Breakthrough Devices
...